HIV Citations List: May 2024
Literature Citations
1. Synthesis of Novel Fluoro Phenyl Triazoles Via Click Chemistry with or without Microwave Irradiation and Their Evaluation as Anti-proliferative Agents in SiHa Cells. Aguilar, J., E. Leyva, S.E. Loredo-Carrillo, A. Cárdenas-Chaparro, A. Martínez-Richa, H. Hernández-López, J.G. Araujo-Huitrado, A.J. Granados-López, Y. López-Hernández, and J.A. López. Current Organic Synthesis, 2024. 21(4): p. 559-570. PMID[37078356].
[PubMed]. HIV_05_2024.
2. Design of Vif-derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction. Gai, Y., S. Duan, S. Wang, K. Liu, X. Yu, C. Yang, G. Li, Y. Zhou, B. Yu, J. Wu, C. Wang, and X. Yu. Viruses, 2024. 16(4). PMID[38675833]. PMCID[PMC11053914].
[PubMed]. HIV_05_2024.
3. An Enzymatic Route to the Synthesis of Tricyclic Fused Hexahydrofuranofuran P2-ligand for a Series of Highly Potent HIV-1 Protease Inhibitors. Ghosh, A.K., A. Sharma, and S. Ghazi. Tetrahedron Letters, 2024. 140. PMID[38586565]. PMCID[PMC10994151].
[PubMed]. HIV_05_2024.
4. Structural Relationships to Efficacy for Prazole-derived Antivirals. Nyenhuis, D.A., S. Watanabe, R. Bernstein, R.E. Swenson, N. Raju, V.R. Sabbasani, C. Mushti, D.Y. Lee, C. Carter, and N. Tjandra. Advanced Science, 2024. 11(18): p. e2308312. PMID[38447164]. PMCID[PMC11095225].
[PubMed]. HIV_05_2024.
5. Structural Elucidation of HIV-1 G-quadruplexes in a Cellular Environment and Their Ligand Binding Using Responsive 19F-labeled Nucleoside Probes. Roy, S., P. Majee, S. Sudhakar, S. Mishra, J. Kalia, P.I. Pradeepkumar, and S.G. Srivatsan. Chemical Science, 2024. 15(21): p. 7982-7991. PMID[38817587]. PMCID[PMC11134374].
[PubMed]. HIV_05_2024.
6. Porphyrins with Combinations of 4-carboxyphenyl and 4-hydroxyphenyl Substituents in Meso-positions as Anti-HIV-1 Agents. Sharma, D., A. Singh, S. Safi, R. Gaur, and D. Sengupta. Scientific Reports, 2024. 14(1): p. 10006. PMID[38693160]. PMCID[PMC11063187].
[PubMed]. HIV_05_2024.
7. Antiviral Activity of Lenacapavir against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-resistant HIV-2 Mutants. Smith, R.A., D.N. Raugi, R.S. Nixon, M. Seydi, N.A. Margot, C. Callebaut, and G.S. Gottlieb. The Journal of Infectious Diseases, 2024. 229(5): p. 1290-1294. PMID[38060982]. PMCID[PMC11095534].
[PubMed]. HIV_05_2024.
8. gp120-derived Amyloidogenic Peptides Form Amyloid Fibrils That Increase HIV-1 Infectivity. Tan, S., W. Li, C. Yang, Q. Zhan, K. Lu, J. Liu, Y.M. Jin, J.S. Bai, L. Wang, J. Li, Z. Li, F. Yu, Y.Y. Li, Y.X. Duan, L. Lu, T. Zhang, J. Wei, L. Li, Y.T. Zheng, S. Jiang, and S. Liu. Cellular & Molecular Immunology, 2024. 21(5): p. 479-494. PMID[38443447]. PMCID[PMC11061181].
[PubMed]. HIV_05_2024.
9. Stabilized Trimeric Peptide Immunogens of the Complete HIV-1 gp41 N-heptad Repeat and Their Use as HIV-1 Vaccine Candidates. Wu, C., I.T. Raheem, D.D. Nahas, M. Citron, P.S. Kim, D.C. Montefiori, E.A. Ottinger, R.W. Hepler, R. Hrin, S.B. Patel, S.M. Soisson, and J.G. Joyce. Proceedings of the National Academy of Sciences of the United States of America, 2024. 121(22): p. e2317230121. PMID[38768344].
[PubMed]. HIV_05_2024.
10. Structure-based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Zhu, X.D., A. Corona, S. Maloccu, E. Tramontano, S. Wang, C. Pannecouque, E. De Clercq, G. Meng, and F.E. Chen. Molecules, 2024. 29(9). PMID[38731613]. PMCID[PMC11085872].
[PubMed]. HIV_05_2024.
Patent Citations
This month, no HIV patents were identified.